STOCK TITAN

Roivant director settles taxes with 5,133 shares

Roivant director Daniel Allen Gold had shares withheld for taxes on a vesting equity grant and continues to hold a large direct position in ROIV.

(Moderate)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Roivant Sciences Ltd. (ROIV) reported that director Daniel Allen Gold had 5,133 Common Shares withheld on September 10, 2026 to satisfy tax withholding obligations in connection with the vesting and settlement of previously granted shares under the Non-Employee Director Compensation Plan. After this net-share tax withholding, he holds 8,960,761 Common Shares directly.

Positive

  • None.

Negative

  • None.
Insider Gold Daniel Allen
Role Director
Type Security Shares Price Value
Tax Withholding Common Shares F1 5,133 $40.94 $210K
Holdings After Transaction: Common Shares — 8,960,761 shares (Direct)
Footnotes (1)
  1. F1. Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.
Shares withheld for tax 5,133 shares Common Shares net settled on September 10, 2026 to cover tax withholding
Reported price per share $40.94 per share Value used for the 5,133-share tax-withholding disposition
Shares held after transaction 8,960,761 shares Daniel Allen Gold’s direct Common Share holdings following the transaction
Shares used for exercise price or tax liability 5,133 shares Total shares reported under code F for payment of tax liability
net settlement financial
"Represents the "net settlement" by the Issuer of Common Shares"
Non-Employee Director Compensation Plan financial
"pursuant to the Issuer's Non-Employee Director Compensation Plan"
tax withholding obligations financial
"to satisfy applicable tax withholding obligations in connection"
Payment of tax liability by delivering or withholding securities financial
"transaction code description: Payment of tax liability by delivering"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Roivant Sciences (ROIV) disclose for Daniel Allen Gold?

Roivant Sciences disclosed that director Daniel Allen Gold had 5,133 Common Shares withheld on September 10, 2026 as a net settlement to cover tax withholding obligations tied to a vesting equity grant.

Was the ROIV Form 4 transaction a market sale or a tax withholding event?

The Form 4 describes a tax-withholding disposition, not an open-market sale. Shares were net settled and withheld by Roivant Sciences to satisfy tax withholding obligations upon vesting of previously granted Common Shares.

How many Roivant Sciences (ROIV) shares were involved in Daniel Allen Gold’s September 10, 2026 transaction?

The transaction involved 5,133 Common Shares of Roivant Sciences that were delivered or withheld to satisfy tax withholding obligations associated with a vesting equity award.

What price per share is reported for Daniel Allen Gold’s ROIV tax-withholding transaction?

The Form 4 reports a price of $40.94 per share for the 5,133 Common Shares used to satisfy tax withholding obligations in the September 10, 2026 net-settlement transaction.

How many Roivant Sciences (ROIV) shares does Daniel Allen Gold own after this Form 4 transaction?

Following the September 10, 2026 tax-withholding transaction, Daniel Allen Gold directly owns 8,960,761 Common Shares of Roivant Sciences, as reported in the Form 4.

Was Daniel Allen Gold’s ROIV Form 4 transaction under a Rule 10b5-1 trading plan?

No Rule 10b5-1 trading plan is indicated. The filing’s Rule 10b5-1 checkbox is not checked, and the footnote describes the event as a tax-withholding net settlement rather than a planned trading program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gold Daniel Allen

(Last)(First)(Middle)
C/O ROIVANT SCIENCES LTD.
7TH FLOOR, 50 BROADWAY

(Street)
LONDONSW1H 0DB

(City)(State)(Zip)

UNITED KINGDOM

(Country)
2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares09/10/2026F5,133(1)D$40.948,960,761D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.
Remarks:
Exhibit 24 - Power of Attorney
By: /s/ Sam Kaplan, as Attorney-in-Fact for Daniel Gold09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading